SEC Stock Data Quick Answer AdaptHealth Corp. reported Diluted EPS of $0.52 per share (loss) for fiscal year 2025. AdaptHealth Corp. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$0.52 -185.2% 2024 $0.61 +111.5% 2023 -$5.31 -1709.1% 2022 $0.33 -50.7% 2021 $0.67 +121.8% 2020 -$3.08 -224.2% 2019 -$0.95 — Quarterly Diluted EPS Quarter Ending … Read more
Quick Answer AdaptHealth Corp. reported Net Income of -$70.79 million for fiscal year 2025. AdaptHealth Corp. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$70.79M -178.3% 2024 $90.42M +113.3% 2023 -$678.89M -1079.4% 2022 $69.32M -55.6% 2021 $156.18M +196.6% 2020 -$161.63M -657.4% 2019 -$21.34M -191.7% 2018 $23.26M +3356571.4% 2017 -$693.00 — Quarterly … Read more
Quick Answer AdaptHealth Corp. reported Revenue (ASC 606) of $3.24 billion for fiscal year 2025. AdaptHealth Corp. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $3.24B -0.5% 2024 $3.26B +1.9% 2023 $3.20B +7.7% 2022 $2.97B +21.0% 2021 $2.45B +132.4% 2020 $1.06B +99.5% 2019 $529.64M +53.4% 2018 $345.28M — Quarterly … Read more
Quick Answer AdaptHealth Corp. reported Total Revenue of $3.24 billion for fiscal year 2025. AdaptHealth Corp. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $3.24B -0.5% 2024 $3.26B +1.9% 2023 $3.20B +7.7% 2022 $2.97B +21.0% 2021 $2.45B +132.4% 2020 $1.06B +99.5% 2019 $529.64M +53.4% 2018 $345.28M — Quarterly Total Revenue Quarter … Read more
Quick Answer AdaptHealth Corp. reported Total Revenue of $3.24 billion for fiscal year 2025. AdaptHealth Corp. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $3.24B-0.5% $3.26B+1.9% $3.20B+7.7% $2.97B+21.0% $2.45B+132.4% $1.06B+99.5% Revenue (ASC 606) $3.24B-0.5% $3.26B+1.9% $3.20B+7.7% $2.97B+21.0% $2.45B+132.4% $1.06B+99.5% Net Income -$70.79M-178.3% $90.42M+113.3% -$678.89M-1079.4% $69.32M-55.6% $156.18M+196.6% -$161.63M-657.4% Diluted EPS … Read more
Quick Answer AGILYSYS INC reported Shares Outstanding of 28.02 million shares for fiscal year 2025. AGILYSYS INC Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 28.02M +2.3% 2024 27.38M +8.1% 2023 25.33M +2.4% 2022 24.73M +3.0% 2021 24.01M +1.7% 2020 23.61M +0.5% 2019 23.50M +0.8% 2018 23.32M +0.5% 2017 23.21M +1.2% … Read more
Quick Answer AGILYSYS INC reported Gross Profit of $171.99 million for fiscal year 2025. AGILYSYS INC Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $171.99M +19.2% 2024 $144.26M +19.4% 2023 $120.82M +19.0% 2022 $101.53M +13.6% 2021 $89.38M +10.4% 2020 $80.95M +9.6% 2019 $73.88M +14.7% 2018 $64.42M +1.0% 2017 $63.78M -6.3% 2016 … Read more
Quick Answer AGILYSYS INC reported Operating Income of $22.59 million for fiscal year 2025. AGILYSYS INC Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $22.59M +43.4% 2024 $15.75M +22.4% 2023 $12.88M +103.8% 2022 $6.32M +130.2% 2021 -$20.96M +38.5% 2020 -$34.06M -160.4% 2019 -$13.08M -8.3% 2018 -$12.08M -5.9% 2017 -$11.41M -164.5% 2016 … Read more
Quick Answer AGILYSYS INC reported R&D Expense of $62.41 million for fiscal year 2025. AGILYSYS INC R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $62.41M +10.0% 2024 $56.74M +12.9% 2023 $50.26M +8.5% 2022 $46.33M -16.3% 2021 $55.34M +33.5% 2020 $41.46M +9.6% 2019 $37.82M +35.4% 2018 $27.94M -3.8% 2017 $29.05M +8.8% 2016 … Read more
Quick Answer AGILYSYS INC reported Stockholders Equity of $265.89 million for fiscal year 2025. AGILYSYS INC Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $265.89M +12.4% 2024 $236.48M +116.3% 2023 $109.31M +12.3% 2022 $97.34M +21.9% 2021 $79.88M +11.3% 2020 $71.76M -28.7% 2019 $100.62M -7.2% 2018 $108.43M -4.6% 2017 $113.67M -7.9% 2016 … Read more